Abstract
Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber disease, is an autosomal-dominant vascular disease characterized by mucocutaneous or visceral angiodysplastic lesions (telangiectases and arteriovenous malformations) that may be widely distributed throughout the cardiovascular system. The recognition of mucocutaneous telangiectases, the occurrence of spontaneous and recurrent episodes of epistaxis, the presence of visceral involvement, and a family history of this disease are the clinical criteria that allow diagnosis. In comparison with skin, lungs, gastrointestinal tract, and brain involvement, hepatic involvement defined by clinical criteria alone has long been considered uncommon. Our experience with a large group of HHT patients, even those asymptomatic for liver involvement, demonstrates that it is more frequent than reported and is characterized by the presence of intrahepatic shunts, disseminated intraparenchymal telangiectases, and other vascular lesions. Congestive cardiac failure, portal hypertension, portosystemic encephalopathy, cholangitis, and atypical cirrhosis have been reported as possible serious complications related to this condition. Thus, a correct diagnosis is important, and diagnostic imaging has a fundamental role in detecting alterations involving the liver. The possibilities to perform a multiphasic study and to provide high-quality multiplanar and angiographic reconstructions, gives multidetector row helical computed tomography the ability to detect and characterize the complex anatomopathologic alterations typical of this disease.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber disease, is a vascular disease with hereditary autosomal-dominant transmission that occurs with an estimated frequency of 10 to 20 per 100,000 individuals [1, 2]. Its typical manifestations are mucocutaneous or visceral angiodysplastic lesions (telangiectases and arteriovenous malformations) that may be widely distributed throughout the cardiovascular system.
The diagnosis of HHT is essentially based on a combination of clinical findings: the recognition of mucocutaneous telangiectases, the occurrence of spontaneous and recurrent episodes of epistaxis, the presence of visceral involvement, and a family history of this disease [3, 4, 5]. At present its pathogenesis is not clear, but it may be a result of genetic mutations that interfere with angiogenesis and its control mechanisms [6, 7, 8, 9, 10, 11].
The organs most frequently involved are the skin, lungs, gastrointestinal tract, and brain [6]; hepatic involvement, almost always defined by clinical criteria, has been considered uncommon, and its prevalence has ranged from 8% to 31% in different studies [3, 12, 13]. In our experience, performed as a retrospective study in a large group of HHT patients, even those with limited clinical symptoms for hepatic involvement, hepatic involvement has proved to be more frequent than reported, likely due to the higher general sensitivity of the imaging method we used in detecting hepatic alterations compared with those used in the past and with clinical findings alone.
The presence of intrahepatic shunts, disseminated intraparenchymal telangiectases, and other vascular lesions are the typical findings of hepatic involvement [13, 14]. Although patients with liver involvement are generally asymptomatic, congestive cardiac failure, portal hypertension, portosystemic encephalopathy, cholangitis, and atypical cirrhosis have been reported [12, 13, 15, 16, 17, 18], so a correct diagnosis is important for the follow-up of symptomatic and asymptomatic patients.
Diagnostic imaging has a fundamental role in the identification of hepatic vascular alterations. Ultrasonography, especially in association with color Doppler, is the usual method for screening patients with HHT and suspected liver involvement [7, 15, 16, 19] because it is readily available, noninvasive, cost effective, and able to demonstrate intraparenchymal shunts and other vascular malformations, and it can provide qualitative and quantitative analyses of the arterial, venous, and portal flows [20].
Angiography previously was the most useful imaging method for the assessment of vascular abnormalities [21, 22, 23], but is currently seems to be indicated only in selected cases for hemodynamic measurements in symptomatic patients or for pre-transplantation workup.
The possibility of performing angiographic reconstructions provided by magnetic resonance imaging (MRI) and helical computed tomography (hCT) have caused them to take on an important role in identifying and characterizing lesions involving hepatic vascular structures.
MRI performed with dynamic and angiographic sequences (angio-MRI) provides information similar to that obtained with CT in the study of hepatic disorders [7, 13, 24, 25, 26].
Helical CT, in particular the multidetector row hCT scanners that can scan three to 10 times faster than can single-detector row hCT, allows a complete multiphasic study of the hepatic vascular system. Compared with traditional hCT, multidetector row hCT also improves the quality of multiplanar reformatting (MPR) and angiographic (maximum intensity projection, MIP; and volume rendering, VR) reconstructions and increases the diagnostic accuracy of this imaging method because it produces thinner section collimation [27].
In this pictorial essay we review our experience with multidetector row hCT and reconstruction software in the evaluation of liver involvement in a large group of HHT patients. The imaging findings obtained with this current hCT technique are shown, and the probable pathologic–radiologic correlations are discussed.
Technique
All studies discussed in this review were performed with a multiphasic technique consisting of a double arterial phase (arterial and arteriolar phases) and a portal venous phase. This type of liver study protocol has been proposed for the assessment of hypervascular hepatocellular carcinoma (HCC) [28, 29, 30], although discordant results have been obtained. Instead, the advantage of supplying a clear temporal separation among the arterial, arteriolar, and venous phases, with different enhancing patterns of parenchyma, arteries, portal, and hepatic veins, may help to detect hypervascular alterations other than HCC, such as shunts or arterial anomalies, thus reducing the risk of misdiagnosis [31].
All the examinations were performed on a four-row multidetector hCT (MX 8000, Marconi Medical System, Cleveland, OH, USA) and carried out with the following parameters: slice collimation, 2.5 mm; pitch, 1.25; increment, 0.6 mm; rotation time, 0.5 s; 120 kVp; and 250 mAs. Multiphasic CT scans were performed with the patients in supine position, through the region of clinical interest, beginning from the hepatic dome (location determined by the scout digital radiograph) and proceeding in a caudal direction to the lower margin of the kidneys. Nonionic contrast medium (Ultravist 370, Schering, Berlin, Germany) was injected into the cubital vein through a 16- to 18-gauge needle by an automatic injector (MK-IV, Medrad, Pittsburgh, PA, USA) by using the following parameters: volume, 1.5 mL/kg body weight with a maximal amount of 150 mL; flow rate, 4 mL/s. The scanning time delay was determined with a test bolus (20 mL at 4 mL/s) of contrast medium followed by a series of single-level CT scans at low dose (120 KVp, 10 mA).
The region of interest (10–20 mm2) was placed over the abdominal aorta below the celiac trunk origin, and scans were acquired every second for 10 to 40 s. The time to peak aortic enhancement was used to determine the scanning delay for the first arterial phase images. The average scanning delay for the early arterial phase (arterial) was 20 s, and that for the late arterial phase (arteriolar or parenchymal), performed after an interscan delay of 5 s for table movement, was 35 s. The portal venous phase was performed 20 s after the end of the second arterial phase. The complete CT scan lasted no longer than 10 min in all cases.
For multiplanar and angiographic rendering, CT data sets were transferred over the Ethernet to a Kayak XU800 workstation (Hewlett Packard, Palo Alto, CA, USA) running VITREA 2.6 reconstruction software (Vital Images, Minneapolis, MN, USA). The application programs used for hepatic involvement assessment were MPR, three-dimensional MIP, and VR, which allowed manipulation of the data set to obtain multiplanar (axial, coronal, and sagittal) and angiographic reconstructions.
Intrahepatic shunts
The presence of intraparenchymal shunts is the most frequent finding associated with HHT disease. Three types of intrahepatic shunts between the major vessels of the liver are possible [32]: arterioportal (hepatic artery to portal vein), arteriosystemic (hepatic artery to hepatic vein), and portosystemic venous (portal vein to hepatic vein or vena cava). Visualization of these shunts on cross-sectional imaging was unusual, but the introduction of dynamic hCT, particularly in association with a multiphasic study protocol, makes their identification easier than in previous decades.
Arterioportal shunts
Intrahepatic arterioportal shunts consist of abnormal communications between the hepatic arteries and the portal veins. Although these shunts may occur in benign hepatic neoplasms or be the consequence of trauma or biopsy procedures, they are typically associated with cirrhosis and HCC in relation to the tendency for these neoplasms to grow in the portal veins [32]. In HHT they represent a congenital vascular malformation and the most common type of shunting isolated or in association with arteriosystemic shunts.
The multiphasic hCT findings of arterioportal shunting are indirect and include the early and prolonged enhancements of the portal vessels during the early arterial phase (Fig. 1). This phase is essential for diagnosing this type of shunt. In normal conditions, during the early arterial phase, the portal veins are not completely filled by the contrast medium, so they are not enhanced or only slightly hyperattenuating. In the late arterial phase, the hepatic parenchyma, portal veins, and sometimes hepatic veins begin to be well enhanced, and this enhancement does not allow definite detection of this kind of hepatic vascular alterations. Like other nontumoral arterioportal shunts, this kind of shunts are typically subcapsular or peripheral and may be associated with focal, increased attenuation, wedge-shaped defects with early portal venous filling [33]. The presence of these areas of perfusion disorder often may be the only sign associated with the intraparenchymal arterioportal shunts.
The hepatic arteries are often enlarged, presumably due to the increased blood flow necessary to compensate for the reduction of hepatopetal portal flow and the decreased peripheral resistance. A dilated portal vein (diameter > 13 mm), often associated with collateral vessels and splenomegaly (longitudinal spleen diameter > 130 mm), is a common finding in HHT patients with arterioportal shunts and is related to the high-pressure blood flow that comes from the hepatic artery filling the portal veins. In the presence of these shunts, these are CT findings of a certain portal hypertension condition. In our experience, an enlarged portal vein also may be evident in patients with arteriosystemic shunts isolated or in association with arterioportal shunts; in this case, only a direct measure of the hepatic wedge pressure could ascertain the presence of portal hypertension. Therefore, in HHT patients, a dilated portal vein without other clinical or instrumental findings should not be interpreted as a definite sign of portal hypertension. However, intrahepatic arterioportal shunts in HHT infrequently may cause a life-threatening portal hypertension that requires emergency surgical or endovascular treatment [32].
Arteriosystemic shunts
These types of shunts, consisting of abnormal communications between hepatic arteries and hepatic veins, are considered rare and typically associated with benign and malignant liver neoplasms [32]. Isolated shunts or more often in association with arterioportal shunts are a frequent finding in the liver parenchyma of HHT patients. Even in this case, their hCT visualization with a multiphasic study is an indirect finding and consists in the early enhancement of one or more than one hepatic veins during the early arterial phase. Usually, during a multiphasic study, hepatic veins become evident in the late phases: in accordance with contrast medium dynamics, the hepatic veins begin to be filled by contrast medium during the late arterial phase, become slightly hyperattenuating, and are completely filled by contrast medium and, hence, strongly enhanced only in the portal-venous phase. The simultaneous opacification of the hepatic artery and the hepatic veins during the early arterial phase is an indirect sign of early venous drainage related to arteriosystemic shunting (Figs. 2, 3). The early filled hepatic vein involved by the shunt may be enlarged.
A high-output cardiac failure attributed to the intrahepatic left-to-right shunt due to arteriosystemic venous shunts is a possible severe complication. In these patients, the CT finding of early visualization of hepatic veins and the inferior vena cava due to shunts also may be referred to the reflux of contrast-enhanced blood from the right atrium into the inferior vena cava and hepatic veins, which often may be enlarged (Fig. 4). These findings often are associated with other signs of passive hepatic congestion such as heterogeneous enhancement (reticulated-mosaic pattern) during the arterial phases and increase of the liver dimensions, including the left and caudate lobes. Ascites and splenomegaly, sometimes visible in these cases, are to be related to the stasis and not to a portal hypertension condition: the portal vein usually is not dilated and collateral vessels are not evident. In such cases with advanced symptoms, the therapeutic role of hepatic arterial embolization has been proposed [23, 34] but is controversial because of its unpredictable results and association with a high risk of fatal hepatic necrosis [35, 36, 37]; thus, liver transplantation remains the only therapeutic possibility [14, 38, 39, 40].
Portosystemic shunts
These type of shunts are usually found in patients with cirrhosis in relation to the increased portal venous pressure that causes the development of a myriad of extra- and intrahepatic portosystemic anastomoses to divert some portal venous blood directly into the systemic venous circulation [41]. The extrahepatic portosystemic collateral pathways are multiple and well known because they are always associated to a portal hypertension condition, whereas intrahepatic anomalous communications between portal veins and systemic veins are typically identified incidentally as part of the workup for cirrhosis or, less commonly, after a patient’s condition has been diagnosed as hepatic encephalopathy [42, 43]. Only few cases of intrahepatic spontaneous portosystemic shunts have been reported in the literature and are rarely seen in HHT patients [17, 44]. Four different morphologic types have been described [42]: the most common type consists of a large vessel connecting the right portal vein to the inferior vena cava; the second type is a shunting between peripheral branches of portal and hepatic veins in one hepatic segment; the third type consists of an aneurysmal peripheral connection between portal and hepatic veins; and the fourth type has multiple communications between peripheral portal and hepatic veins diffusely in both lobes.
The angiographic and sonographic findings of these types of shunts recently have been well described [45, 46], but portosystemic venous shunts may be difficult to detect with hepatic angiography in patients with predominant arteriosystemic shunts. In these patients, high-pressure arterial flow from the hepatic artery via arteriovenous shunts is present in hepatic veins, and pulsed or color Doppler examination may be helpful to detect small arterioportal shunts and proximally located portosystemic shunts [46]. CT diagnosis remains difficult, probably due to the impossibility, even with a multiphasic liver study, to clearly separate a “portal” from a “venous” phase and “early” arterial from “late” arterial from portal-venous phase. Thus, the only CT finding is direct evidence during the portal-venous phase of dilated portal veins communicating with a large systemic or hepatic vein. Sometimes the communication is seen as dilated paraumbilical veins with an intrahepatic course [47].
We do not have cases of direct visualization of a communication between these two vascular channels, but their presence always must be sought, especially before embolization treatment in symptomatic patients. In presence of this type of shunt, the liver is supplied by blood from the hepatic artery alone because much of the portal blood flow enters the hepatic veins directly through these shunts. In this case, portal blood flow to the liver will be inadequate after hepatic artery embolization, and life-threatening liver infarction will occur [46].
Perfusion disorders
Intraparenchymal perfusion disorders such as transient hepatic attenuation differences (THADs) represent the epiphenomenon of alterations of the dual hepatic vascular system (70–75% portal vein, 25–30% hepatic artery), and their most common cause is low portal inflow due to obstruction (e.g., thrombosis of a portal vessel) in forms not associated with focal lesions and due to compression in those with associated focal lesions, even though some malignancies and abscesses can induce thrombosis. In HHT patients, this phenomenon is frequently associated with the presence of arterioportal shunts, reflecting the blood flow alteration induced by the shunt, and its evidence should be interpreted as another indirect sign of the presence of these types of shunts. Indeed, the presence of shunts determines a diversion of the portal flow by a higher-pressure arterial flow, thereby creating a relatively low portal inflow that induces a compensatory preferential redistribution of arterial flow to a hepatic lobe or segment that therefore appears enhanced [18, 48]. Thus, in THADs related to arterioportal shunting, there is no portal block but a mixing of arterial and venous blood. These hepatic perfusion disorders appear during the arterial phases as high-attenuation parenchymal areas that become isoattenuating on portal-phase images. Such areas of transient enhancement are usually peripheral and wedge shaped with straight margins and of lobar, segmental, or subsegmental distribution [49], but sometimes they display globular or pseudo-globular morphology: the axial section of a conical shape may appear round or oval (Fig. 5) [50, 51]. Hence, they are not distinguishable from small HCC foci and in these cases differential diagnostic problems may arise.
Vascular lesions
The disorders of angiogenesis control mechanisms typical of HHT may explain the occurrence of other lesion-like vascular abnormalities in the liver parenchyma: telangiectases and large confluent vascular masses (LCVMs).
We consider as parenchymal hepatic telangiectases the rounded, strongly enhanced lesions with a diameter smaller than 10 mm and a predominantly peripheral arrangement. These vascular ectasias are, perhaps, analogous to those found on the nose, skin, and in the gastrointestinal tract and appear as round formations, with a diameter of 5 to 7 mm, which form relations with vascular branches having their same attenuation (Figs. 1, 4, 6). These small vascular spots also are better recognizable in the reconstructed MPR and MIP images that enhance the difference in density between hepatic parenchyma and vascular structures (Fig. 7).
The term LCVMs, not mentioned before in the literature, has been introduced by us to describe the aspect and likely underlying formation process of the lesions with a diameter larger than 10 mm. In our experience, they appear as large vascular pools characterized by early and persistent enhancement during the arterial phases after contrast medium injection (Figs. 1, 6). Presumably they are large areas of multiple telangiectases that coalesce or large shunts that are directly visible. Sometimes LCVMs represent THADs with globular or pseudo-globular morphology or capillary hemangiomas.
The number and size of these vascular lesions increase in the late arterial phase, but their differentiation from vascular branches is easier during the first arterial phase because of lesser enhancement of the portal and hepatic veins and of the hepatic parenchyma (Fig. 8).
Conclusions
The assessment of hepatic involvement in HHT patients is important from the clinical point of view because the presence of any vascular alterations has a higher frequency than reported and, even if usually asymptomatic, may induce serious complications. Diagnosis of the pathology is based on clinical and historical data, and diagnostic imaging has a fundamental role in detecting the disorders involving the different anatomic regions. The possibility to perform a multiphasic study of the liver and to provide high-quality multiplanar and angiographic reconstructions gives multidetector row hCT the ability to detect and characterize the complex anatomopathologic alterations typical of this disease.
References
M Dakeishi T Shioya Y Wada et al. (2002) ArticleTitleGenetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19 140–148 Occurrence Handle10.1002/humu.10026 Occurrence Handle1:CAS:528:DC%2BD38XhsVKrsL0%3D Occurrence Handle11793473
AD Kjeldsen P Vase A Green (1999) ArticleTitleHereditary hemorrhagic telangiectasia, HHT. A population based study of prevalence and mortality in Danish HHT patients. J Intern Med 245 31–41 Occurrence Handle10.1046/j.1365-2796.1999.00398.x Occurrence Handle1:STN:280:DyaK1M7psFGiug%3D%3D Occurrence Handle10095814
H Plauchu JP de Chadarevian A Bideau JM Robert (1989) ArticleTitleAge-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32 291–297 Occurrence Handle10.1002/ajmg.1320320302 Occurrence Handle1:STN:280:DyaL1M3ntVGrtA%3D%3D Occurrence Handle2729347
CL Shovlin AE Guttmacher E Buscarini et al. (2000) ArticleTitleDiagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 66–67 Occurrence Handle10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P Occurrence Handle1:STN:280:DC%2BD3c3htlWntg%3D%3D Occurrence Handle10751092
DA Marchuk AE Guttmacher JA Penner P Ganguly (1998) ArticleTitleReport on the workshop on hereditary hemorrhagic telangiectasia, July 10–11, 1997. Am J Med Genet 76 269–273 Occurrence Handle10.1002/(SICI)1096-8628(19980319)76:3<269::AID-AJMG12>3.0.CO;2-F Occurrence Handle1:STN:280:DyaK1c7mslKksQ%3D%3D Occurrence Handle9508248
AE Guttmacher DA Marchuk RI White Jr (1995) ArticleTitleHereditary hemorrhagic telangiectasia. N Engl J Med 333 918–924 Occurrence Handle10.1056/NEJM199510053331407 Occurrence Handle1:STN:280:DyaK2Mzps1ensg%3D%3D Occurrence Handle7666879
E Buscarini L Buscarini G Civardi et al. (1994) ArticleTitleHepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings. AJR 163 1105–1110 Occurrence Handle1:STN:280:DyaK2M%2FmslCltA%3D%3D Occurrence Handle7976883
KA McAllister KM Grogg DW Johnson et al. (1994) ArticleTitleEndoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8 345–351 Occurrence Handle10.1038/ng1294-345 Occurrence Handle1:CAS:528:DyaK2MXitl2hsLo%3D Occurrence Handle7894484
JN Berg CJ Gallione TT Stenzel et al. (1997) ArticleTitleThe activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61 60–67 Occurrence Handle10.1086/513903 Occurrence Handle1:CAS:528:DyaK2sXlsFCrur0%3D Occurrence Handle9245985
DW Johnson JN Berg MA Baldwin et al. (1996) ArticleTitleMutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 13 189–195 Occurrence Handle10.1038/ng0696-189 Occurrence Handle1:CAS:528:DyaK28XktlOhur4%3D Occurrence Handle8640225
CL Shovlin M Letarte (1999) ArticleTitleHereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54 714–729 Occurrence Handle10.1136/thx.54.8.714 Occurrence Handle1:STN:280:DyaK1MzktlyltQ%3D%3D Occurrence Handle10413726
PJ Reilly TT Nostrant (1984) ArticleTitleClinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 79 363–367 Occurrence Handle1:STN:280:DyaL2c3gtVSrtQ%3D%3D Occurrence Handle6609633
G Bernard F Mion L Henry et al. (1993) ArticleTitleHepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological and hemodynamic studies of 11 cases. Gastroenterology 105 482–487 Occurrence Handle1:STN:280:DyaK3szivVSnuw%3D%3D Occurrence Handle8335203
G Garcia-Tsao JR Korzenik L Young et al. (2000) ArticleTitleLiver disease in patient with hereditary hemorrhagic telangiectasia. N Engl J Med 343 931–936 Occurrence Handle10.1056/NEJM200009283431305 Occurrence Handle1:STN:280:DC%2BD3cvlvF2qtQ%3D%3D Occurrence Handle11006369
HM Cloogman RD Di Capo (1984) ArticleTitleHereditary hemorrhagic telangiectasia: sonographic findings in the liver. Radiology 150 521–522 Occurrence Handle1:STN:280:DyaL2c%2Fps1eltQ%3D%3D Occurrence Handle6691112
PW Ralls MB Johnson DR Radin et al. (1992) ArticleTitleHereditary hemorrhagic telangiectasia: findings in the liver with color Doppler sonography. AJR 159 59–61 Occurrence Handle1:STN:280:DyaK38zgtlCrsw%3D%3D Occurrence Handle1609722
H Naganuma H Ishida M Niizawa et al. (1995) ArticleTitleHepatic involvement in Osler-Weber-Rendu disease: findings on pulsed and color Doppler sonography. AJR 165 1421–1425 Occurrence Handle1:STN:280:DyaK28%2Fnt1Kruw%3D%3D Occurrence Handle7484577
S Quiroga C Sebastia E Pallisa et al. (2001) ArticleTitleImproved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT. Radiographics 21 65–81 Occurrence Handle1:STN:280:DC%2BD3MzgtFCitw%3D%3D Occurrence Handle11158645
V Vilgrain Y Menu H Nahum (1991) ArticleTitleDoppler sonography in Osler-Weber-Rendu disease. AJR 157 413–414 Occurrence Handle1:STN:280:DyaK3Mzgs1ylsQ%3D%3D Occurrence Handle1853834
G Bodner S Peer M Karner et al. (2002) ArticleTitleNontumorous vascular malformations in the liver. Color Doppler ultrasonographic findings. J Ultrasound Med 21 187–197 Occurrence Handle11833874
U Nyman (1977) ArticleTitleAngiography in hereditary hemorrhagic telangiectasia. Acta Radiol Diagn (Stockh) 18 581–592 Occurrence Handle1:STN:280:DyaE1c%2FlslOktQ%3D%3D
ML Thomas H Carty (1974) ArticleTitleHereditary hemorrhagic telangiectasia of the liver demonstrated angiographically. Acta Radiol Diagn (Stockh) 15 433–438 Occurrence Handle1:STN:280:DyaE2M%2FhtVKiuw%3D%3D
A Chavan M Galanski S Wagner et al. (1998) ArticleTitleHereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations—experience in five patients. Radiology 209 735–739 Occurrence Handle1:STN:280:DyaK1M%2FmtVKmtQ%3D%3D Occurrence Handle9844667
DG Varma SG Schoenberger A Kumra et al. (1989) ArticleTitleOsler-Weber-Rendu disease: MR findings in the liver. J Comput Assist Tomogr 13 134–135 Occurrence Handle10.1097/00004728-198901000-00031 Occurrence Handle1:STN:280:DyaL1M%2FptlGqtg%3D%3D Occurrence Handle2910932
R Manfredi AM De Gaetano L Natale (1993) ArticleTitleNon-invasive integrated imaging of Rendu-Osler disease with hepatic involvement. Radiol Med (Torino) 86 922–925 Occurrence Handle1:STN:280:DyaK2c7is1Giuw%3D%3D
L Bonomo A Carriero A Maggialetti (2001) Storia di una metodica. L Bonomo A Carriero A Maggialetti (Eds) Angiografia con risonanza magnetica—circolo periferico, 1st ed. Idelson-Gnocchi Naples, Italy 3–15
G Rydberg KA Buckwalter KS Caldemeyer et al. (2000) ArticleTitleMultisection CT: scanning techniques and clinical application. Radiographics 20 1787–1806 Occurrence Handle1:STN:280:DC%2BD3M7gtlSisA%3D%3D Occurrence Handle11112829
T Murakami T Kim M Takamura et al. (2001) ArticleTitleHypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 218 763–767 Occurrence Handle1:STN:280:DC%2BD3M3gs1Cjsg%3D%3D Occurrence Handle11230652
T Kim T Murakami M Hori et al. (2002) ArticleTitleSmall hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR 178 899–904 Occurrence Handle11906869
T Ichikawa T Kitamura H Nakajima et al. (2002) ArticleTitleHypervascular hepatocellular carcinoma: can double arterial-phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?. AJR 179 751–758 Occurrence Handle12185057
T Murakami T Kim S Takahashi H Nakamura (2002) ArticleTitleHepatocellular carcinoma: multidetector row helical CT. Abdom Imaging 27 139–146 Occurrence Handle10.1007/s00261-001-0090-z Occurrence Handle1:STN:280:DC%2BD387hsVCjsg%3D%3D Occurrence Handle11847573
MJ Lane RB Jeffrey DS Katz (2000) ArticleTitleSpontaneous intrahepatic vascular shunts. AJR 174 125–131 Occurrence Handle1:STN:280:DC%2BD3c%2Fpt1Snug%3D%3D Occurrence Handle10628467
TK Kim BI Choi JK Han et al. (1998) ArticleTitleNontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings. Radiology 208 597–603 Occurrence Handle1:STN:280:DyaK1czptVSmug%3D%3D Occurrence Handle9722834
M Caselitz S Wagner A Chavan et al. (1998) ArticleTitleClinical outcome of transfemoral embolization in patients with arteriovenous malformation of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut 42 123–126 Occurrence Handle10.1136/gut.42.1.123 Occurrence Handle1:STN:280:DyaK1c7ms1OqtA%3D%3D Occurrence Handle9505897
JE Jackson (1999) ArticleTitleHepatic vascular malformations in hereditary hemorrhagic telangiectasia: treatment with embolization. Radiology 213 927–928 Occurrence Handle1:STN:280:DC%2BD3c%2Fls1Omsw%3D%3D Occurrence Handle10580978
FJ Miller JH Whiting Jr JR Korzenik RI White (1999) ArticleTitleCaution with use of hepatic embolization in the treatment of hereditary hemorrhagic telangiectasia. Drs Chavan and colleagues respond. Radiology 213 928–930 Occurrence Handle10580979
JH Whiting Jr JR Korzenik FJ Miller et al. (2000) ArticleTitleFatal outcome after embolotherapy for hepatic arteriovenous malformation of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol 11 855–858 Occurrence Handle10.1016/S1051-0443(07)61800-4 Occurrence Handle1:STN:280:DC%2BD3M%2FjsVClsQ%3D%3D
T Bauer P Britton D Lomas et al. (1995) ArticleTitleLiver transplantation for hepatic arteriovenous malformation in hereditary hemorrhagic telangiectasia. J Hepatol 22 586–590 Occurrence Handle10.1016/0168-8278(95)80455-2 Occurrence Handle1:STN:280:DyaK2MznvVKhtg%3D%3D Occurrence Handle7650340
O Boillot F Bianco JP Viale et al. (1999) ArticleTitleLiver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology 116 187–192 Occurrence Handle10.1016/S0016-5085(99)70243-X Occurrence Handle1:STN:280:DyaK1M%2Fosl2ktQ%3D%3D Occurrence Handle9869617
R Pfitzmann M Heise JM Langrehr et al. (2001) ArticleTitleLiver transplantation for treatment of intrahepatic Osler’s disease: first experiences. Transplantation 72 237–241 Occurrence Handle10.1097/00007890-200107270-00012 Occurrence Handle1:STN:280:DC%2BD3MvktFWisw%3D%3D Occurrence Handle11477345
K Ito M Higuchi T Kada et al. (1997) ArticleTitleCT of acquired abnormalities of the portal venous system. Radiographics 17 897–917 Occurrence Handle1:STN:280:DyaK2szmvVOktA%3D%3D Occurrence Handle9225390
JH Park SH Cha JK Han MC Han (1990) ArticleTitleIntrahepatic portosystemic venous shunt. AJR 155 527–528 Occurrence Handle1:STN:280:DyaK3czltVKitg%3D%3D Occurrence Handle2117349
H Mori K Hayashi T Fukuda et al. (1987) ArticleTitleIntrahepatic portosystemic venous shunt: occurrence in patients with and without liver cirrhosis. AJR 149 711–714 Occurrence Handle1:STN:280:DyaL2szit1ygsQ%3D%3D Occurrence Handle3307352
D Michaeli I Ben-Bassat HI Miller V Deutsch (1968) ArticleTitleHepatic telangiectases and portosystemic encephalopathy in Osler-Weber-Rendu disease. Gastroenterology 54 929–932 Occurrence Handle1:STN:280:DyaF1c3ntFKrug%3D%3D Occurrence Handle5652528
M Matsuo M Kanematsu H Kato et al. (2001) ArticleTitleOsler-Weber-Rendu disease: visualizing portovenous shunting with three-dimensional sonography. AJR 176 919–920 Occurrence Handle1:STN:280:DC%2BD3M7msF2ltQ%3D%3D Occurrence Handle11264078
M Hashimoto E Tate T Nishii et al. (2003) ArticleTitleAngiography of hepatic vascular malformations associated with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 26 177–180 Occurrence Handle10.1007/s00270-002-1507-Y Occurrence Handle1:CAS:528:DC%2BD3sXisVKhs7Y%3D Occurrence Handle12813620
Y Itai Y Kurosaki Y Saida et al. (1994) ArticleTitleCT and MRI in detection of intrahepatic portosystemic shunts in patients with liver cirrhosis. J Comput Assist Tomogr 18 768–773 Occurrence Handle1:STN:280:DyaK2cznsFKqsw%3D%3D Occurrence Handle8089327
JH Oliver III RL Baron (1996) ArticleTitleHelical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. Radiology 201 1–14
WP Chen JH Chen JI Hwang et al. (1999) ArticleTitleSpectrum of transient hepatic attenuation differences in biphasic helical CT. AJR 172 419–424 Occurrence Handle1:STN:280:DyaK1M7isl2rtw%3D%3D Occurrence Handle9930795
S Colagrande N Centi L Carmignani et al. (2003) ArticleTitleMeaning and etiopathogenesis of sectorial transient hepatic attenuation differences (THAD). Radiol Med 105 180–187 Occurrence Handle12835641
Y Itai O Matsui (1997) ArticleTitleBlood flow and liver imaging. Radiology 202 306–314 Occurrence Handle1:STN:280:DyaK2s7mslemug%3D%3D Occurrence Handle9015047
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Memeo, M., Stabile Ianora, A., Scardapane, A. et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: . Abdom Imaging 29, 211–220 (2004). https://doi.org/10.1007/s00261-003-0101-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-003-0101-3